PsyMed Ventures

2020

Founded

3

Investments

United States

Offices

Venture Fund

Investor Type

About

PsyMed Ventures is a venture capital firm dedicated to revolutionizing brain and mental health through innovative neuroscience and frontier technologies. The firm focuses on investing in frontier technologies transforming the mental and brain illness epidemic into a flourishing future. Their investment areas include Artificial Intelligence, Neurotech & Human Augmentation, Precision Psychiatry, Digital Therapeutics, Holistic Medicine, Metabolic Psychiatry, and Psychedelic Medicine & New Compounds.

PsyMed Ventures supports founders who align healing, responsibility, and profitability.

Investment Focus

No items found.

Portfolio Companies

Alto Neuroscience, Ancilia, Atai Life Sciences, Beckley Psytech, Bexson Biomedical, Bloom Science, Bright Minds, Delix Therapeutics, Freedom Biosciences, Gilgamesh Pharmaceuticals

Gepgraphic Focus

Global

Key Differentiators

Focus on frontier technologies transforming mental and brain health, Support for founders aligning healing, responsibility, and profitability

Thypical Investment Size

Not publicly disclosed

Total Funds Raised

Not publicly disclosed

Visit Website

San Francisco

Seed

Series A

Series B

Series C

Series D

United States